Scorpions ‘taking over' Brazilian cities with reported stings rising 250%
Scorpions are 'taking over' Brazilian cities, researchers have warned in a paper that said rapid urbanisation and climate breakdown were driving an increase in the number of people being stung.
More than 1.1m stings were reported between 2014 and 2023, according to data from the Brazilian notifiable diseases information system. There was a 250% increase in reports of stings from 2014 to 2023, according to research published in the journal Frontiers in Public Health.
The rise in cases has been driven by rapid, unplanned urbanisation – such as favelas – characterised by high-density housing and poor waste disposal, according to the research. Although urban areas are encroaching on wild habitats where scorpions already live, they are also creating new environments in which to thrive.
'Urbanisation in Brazil has profoundly reshaped ecosystems,' said the lead researcher, Manuela Berto Pucca, an assistant professor at São Paulo State University. 'Cities unintentionally offer everything scorpions need: plenty of shelter (in walls, drains, rubble and construction debris), consistent warmth, and a reliable food supply in the form of cockroaches and other urban invertebrates.'
They particularly like sewers, which are warm year-round, home to almost no predators and provide plenty of food, especially cockroaches. Some species of scorpion can survive for up to 400 days without food and are able to reproduce without mating, making them difficult to eradicate. Scorpions thrive in urban environments such as sewers, which are warm and humid and have a ready food supply in the form of cockroaches. Photograph: Nelson Almeida/AFP/Getty Images
Hotter summers, and periods of intense rainfall and drought, also help them thrive as they are adapted to warm and humid environments.
Provisional data for 2024 suggests scorpions were responsible for nearly 200,000 stings and 133 deaths in Brazil. In total, researchers projected 2m new cases between 2025 and 2033. 'The real scale of this issue is likely far greater than the recorded statistics suggest,' researchers said, as many people choose to treat themselves at home, or forgo treatment.
'I've been working in places where scorpion stings are a daily fear, especially in poor and crowded areas,' said Pucca. 'The numbers showed us that in the future the problem will be bigger than it is now.'
Researchers said that 0.1% of reported stings result in death, and children and elderly people are most vulnerable. Healthy people generally make a full recovery, but can suffer from pain and discomfort for several days. Symptoms include pain, burning, swelling, redness, tingling and nausea.
Previous research modelling the distribution of scorpions in Brazil showed the potential to expand their habitats into urban areas driven by a warmer, wetter climate.
Brazil, Paraguay, Bolivia, Mexico, Guyana and Venezuela have witnessed a 'particularly alarming rise in scorpionism [the medical condition resulting from a sting] over recent decades, evolving into a significant public health crisis', the researchers of the new study said. In Europe there are believed to be more than 35 native species of scorpion, although there is no comprehensive research on population trends.
Researchers said prevention was key. 'Scorpions thrive in cluttered, humid environments. Keep areas clean, seal cracks in walls, use screens on drains and always check shoes, towels and clothes before using them,' said Pucca.
Dr Manuela González-Suárez, an ecologist at Reading University who was not involved in the research, said: 'The numbers are much higher than I would expect, in the sense that this is a significant increase.' However, she said awareness of an issue could also result in more reporting.
González-Suárez added that people should not be unduly alarmed by the research: 'Many people who are stung do not have severe or lethal reactions and mortality rates are relatively low compared with, for example, those due to road accidents or violent crimes.' Scorpion anti-venoms are available at some Brazilian hospitals and people are urged to seek treatment immediately if stung. Photograph: Nelson Almeida/AFP/Getty
The Brazilian health system provides free treatment for scorpion stings, and anti-venom is available at some hospitals and emergency centres. 'If someone is stung, don't wait for symptoms to worsen – go to the nearest healthcare facility immediately,' said one of the paper's authors, Prof Eliane Candiani Arantes from the University of São Paulo.
'All people are vulnerable, especially children, because just one small sting can kill a child,' she said.
Prof Nibedita Ray-Bennett, at the University of Leicester, who is president of the Avoidable Deaths Network, said the study underscored 'the urgent need for action'.
Pucca said one of the most widespread misconceptions about scorpions was that they were our enemies. 'They are not. These animals act defensively, not offensively. They're part of the natural world and play essential ecological roles, from controlling pest populations to maintaining biodiversity.'
Find more age of extinction coverage here, and follow the biodiversity reporters Phoebe Weston and Patrick Greenfield in the Guardian app for more nature coverage
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
New virus discovered in China is 'one small step' away from triggering a pandemic, scientists warn
A dangerous new coronavirus discovered in China could spark the next pandemic, scientists warn. American researchers say the new HKU5-CoV-2 virus is just one 'small' mutation away from being able to infect and cause outbreaks in humans. The discovery is causing alarm because the pathogen is closely related to MERS, a highly lethal virus that kills up to a third of those it infects. Adding to the controversy is the fact HKU5 was first documented in bats by researchers from the Chinese lab where Covid is feared to have leaked from. For the latest study, a team from Washington State University studied how the new pathogen interacts with human cells in lab experiments. Professor Michael Letko, a virologist at Washington State who co-led the study, said: 'HKU5 viruses in particular really hadn't been looked at much, but our study shows how these viruses infect cells. 'What we also found is HKU5 viruses may be only a small step away from being able to spill over into humans.' The findings reveal that a small change in the virus's spike protein could enable it to bind to human ACE2 cells, which are found in people's throats, mouths and noses. Researchers collected the HKU5-CoV-2 strain from a small subset of hundreds of bats swabbed across southern and eastern regions of China. It is currently only spreading in bats - but experts fear unregulated wildlife trade in China raises risk of spillover events. In their experiments, the researchers used gene-editing tools to create 'pseudoviruses', lab-made virus particles that include the HKU5 spike protein but are harmless and don't replicate. These pseudoviruses were introduced to different types of cells, some carrying bat ACE2 and others carrying human ACE2. The virus glowed green when it successfully entered and replicated inside a cell. Bat cells lit up brightly, showing HKU5 can easily infect them. Human cells, however, showed little response unless the virus carried specific mutations that improved its ability to latch onto ACE2. The results raise concern that if HKU5 jumps to an intermediate animal, such as mink or civets, it could acquire mutatations before reaching humans. The FBI and CIA believe COVID-19 most likely originated from a lab leak at the Wuhan Institute of Virology, which was working with dangerous coronaviruses in the years leading up to the pandemic. Another theory points to a wet market, where dozens of animals were kept in squalid conditions, possibly serving as an intermediate host before the virus jumped to humans. The new study published in the Nature Communications, focused on a lesser-known group of coronaviruses known as merbecoviruses, which includes HKU5 and MERS-CoV, the virus responsible for Middle East Respiratory Syndrome first identified in Saudi Arabia in 2012. MERS spreads from camels to humans and has a fatality rate of about 34 percent. To visualize the virus's structure, scientists used cryo-electron microscopy, a high-resolution imaging method that allowed them to examine the spike protein in detail. They found that key parts of the spike remained in a 'closed' position, which makes infection more difficult, but not impossible. 'These viruses are so closely related to MERS, so we have to be concerned if they ever infect humans,' Letko said. 'While there's no evidence they've crossed into people yet, the potential is there and that makes them worth watching.' Earlier this year, scientists in Wuhan reported that one strain of HKU5, Lineage 2, could already bind to human ACE2 receptors. That means it might infect human cells without needing to evolve further. Now, US researchers have broadened the investigation, studying the entire merbecovirus family, not just one strain, but dozens, including MERS-CoV and multiple HKU5 variants, to better understand their potential to infect human cells. Lineage 2 appears more immediately dangerous, already equipped to enter human cells. But this new study reveals that several other type of HKU5 viruses may only be a few mutations away from doing the same.
The Independent
5 hours ago
- The Independent
Study finds deceptively simple solution to attractiveness beats botox
Botox promises smoother, wrinkle free skin and a fresher face, but researchers have found there is a much cheaper option if looking more attractive is the aim - simply smiling. Researchers found injectable treatments such as dermal fillers and Botox boosted the participants perceived attractiveness by 0.07 points on a seven points scale. That means if someone was rated a four out of seven on attractiveness before the treatment might have been rated a 4.07 out of seven afterwards. However, there were far simpler methods that did not involve a needle that reaped even greater rewards. Simply smiling rather than sitting with a blank expression improved perceived attractiveness by about 0.4 points out of seven – that's six times greater than the effects of Botox. Make-up also offered an even greater attractiveness boost of about 0.6 points. Botox is the brand name for botulinum toxin an injectable prescription medication that's used to temporarily block nerve signals to muscles causing them to relax, and as a result, smooth out wrinkles. But prices for the treatment start at around £300- making make-up a far cheaper option if you are looking to make yourself appear more attractive. The study, conducted by researchers in the Netherlands and published in the journal Perception, followed 114 people who underwent Botox and dermal filler treatments. More than 3,000 judges marked their changes in appearance from before and after photographs. They judged attractiveness and other character traits including how intelligent they were, charismatic, healthy, friendly or trustworthy just from looks. Although Botox did not boost a person's perceived intelligence or health, it did boost how youthful people were perceived to be by 0.13 points. There was also a small but statistically significant boost of 0.09 points for how desirable people were seen to be for a short romantic fling. Similarly, Botox gave a 0.09-point increase for platonic likability. But when it came to how desirable people were perceived to be as a potential long-term partner there was no statistically significant improvement. 'Our results suggest that a single session of minimally invasive facial aesthetic treatment leads to more positive perceptions on dimensions related to attractiveness, but these effects are relatively small,' study authors said. But researchers also suggested that people seek out treatments such as Botox to 'improve feelings of self-worth, confidence, and happiness' rather than their attractiveness. Bastian Jaeger of Tilburg University, who led the research told the Times: 'It is plausible that people have more success socially, not because they look different and people treat them differently, but because they think they do and act more confidently around others — a sort of a self-fulfilling prophecy.'
The Independent
6 hours ago
- The Independent
Menopause treatment linked to longer survival in breast cancer patients
A recent study in the U.S. has found that estrogen creams, commonly used to alleviate menopause symptoms, are not only safe for older women diagnosed with breast cancer, but may also correlate with increased survival rates. The research, which was presented at the ASCO meeting, indicated that postmenopausal breast cancer survivors who used hormone creams experienced a reduced risk of disease progression, recurrence, or death. These findings challenge previous concerns that the creams could stimulate the growth of breast cancer cells that rely on hormones. Vaginal estrogen creams are frequently used to treat menopause symptoms such as vaginal dryness, discomfort and pain during intercourse. As a result of previous concerns, many breast cancer survivors avoid these treatments. Researchers reviewed national database records on 18,620 female breast cancer patients aged 65 and older who were diagnosed between 2010-2017, including 800 who used vaginal estrogen creams. After accounting for patients' race, cancer stage, treatments and other factors, the researchers saw a statistically significant increase in overall survival among patients who used vaginal estrogen. The cream users also had a significant increase in breast cancer-specific survival, the interval from diagnosis to death from breast cancer. On average, estrogen cream users had a 47 per cent lower risk of dying from breast cancer and a 44 per cent lower risk of death from any cause during the study period, compared to non-users. Even in patients whose tumours were known to use hormones for growth, estrogen cream use was associated with a 38 per cent lower risk of death from any cause. Main symptoms of breast cancer in women NHS Estrogen cream users with hormone-positive breast cancer also had a lower risk of death from breast cancer, but that difference was not statistically significant. Use of the creams for more than seven years appeared to confer an additional survival benefit. 'These findings add to a rising contemporary paradigm shift that local hormone therapy is not associated with increased risk to overall or breast cancer-specific survival, which has important clinical implications,' the researchers said.
